Plain-English translation of NCT06431100 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new cell therapy called GK01, which uses your own immune cells to fight advanced cancer. Doctors will remove a sample of your tumor, grow special cancer-fighting cells from it in the laboratory, and then give those cells back to you through an infusion. The study will watch how safe this treatment is and whether it helps shrink your cancer.
Many patients with advanced cancers stop responding to standard treatments. This medication tries a different approach by harnessing your body's own immune system to recognize and attack cancer cells that have learned to hide from ordinary treatments.
You likely qualify if…
You likely don't qualify if…
You will first have a biopsy or fluid collection to obtain tumor cells, which are then sent to a laboratory to grow your personalized immune cells. Once the cells are ready, you will return to the clinic to receive an infusion of these cells. The research team will then follow you closely to monitor your safety, check your blood work, and use imaging scans to see if your cancer is responding to this treatment.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
China